Cesarean Delivery Completed Phase 4 Trials for Cefazolin (DB01327)

IndicationStatusPhase
DBCOND0036001 (Cesarean Delivery)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01755026Serum and Tissue Cefazolin Concentrations in Patients Undergoing Cesarean DeliveryBasic Science